Protective perioperative strategy using a third generation hydroxyethyl starch during surgery in a murine model of liver reperfusion injury 1 Estratégia protetora perioperatória usando um hidroxietilamido de terceira geração para expansão volêmica durante a cirurgia em modelo murino de lesão de reperfusão hepática 
Introduction
Ischemia/reperfusion injury (IRI) to the liver is commonly encountered in clinical situations such as hemorrhagic shock, septic shock, abdominal surgeries, major hepatectomy and liver transplantation, especially if surgery is performed in patients with severe liver disease 1, 2 . In these settings, substantial hepatocellular damage occurs during restoration of hepatic blood flow after a period in which circulation is extensively disrupted. Following the hypoxemic injury in the ischemic period, the subsequent reintroduction of oxygen into the liver leads to an aggressive inflammatory response. This occurs in two phases: the acute injury phase (early-phase), which is characterized by liver injury occurring within 1-6 hours after reperfusion, is associated with Kupffer cell activation, release of the pro-inflammatory cytokines, and generation of reactive oxygen species; the subacute-phase response (late-phase), which extends from 6 up to 24 hours of reperfusion in the rat model, is characterized by an extensive neutrophil infiltration and further production of the inflammatory By using an appropriate liver IRI rat model, the present study was designed to test the hypothesis that HES 130/0.4 has a protective effect in the late-phase of liver IRI (24 hours of reperfusion) and that this protection is associated with antiinflammatory properties. They injected the solutions intravenously at the onset of reperfusion at a volume of 13 mL/kg body weight. Mortality was registered.
Methods

Animals and experimental design
Animals were humanely killed after 24 hours of reperfusion and blood was drawn for serum alanine aminotransferase (ALT) quantification and ischemic liver samples were taken for histological study by light microscopy (hematoxylin and eosin and chloroacetate staining of neutrophils). Codes were used to mask the groups in ALT serum determinations and histopathological samples.
Rat model of hepatic ischemia/reperfusion injury
We selected a non-lethal model of segmental (70%) hepatic ischemia to allow prevention of mesenteric congestion. All surgical procedures were performed on intramuscular ketamine (115 mg/kg) and chlorpromazine (3.5 mg/kg) anesthetized animals, with body temperatures maintained at 37°C. A midline abdominal incision was performed to enter the peritoneal cavity.
In groups which included IRI induction, a microvascular clamp At the defined end-point (24 hours of reperfusion), the rats were re-anesthetized and blood was drawn from the aorta for ALT quantification and ischemic liver tissue samples were taken for subsequent histomorphological study. The surviving animals were killed by exsanguination.
Serum alanine aminotransferase levels
Serum ALT levels were evaluated based on the following protocol: blood samples were centrifuged to separate the plasma.
Plasma samples were stored at -20ºC until use for ALT assay. 
Histological examination and photoimage analysis
At necropsy, liver samples from all rats were collected for histopathologic evaluation. Tissues were fixed in 10%
formalin, embedded in paraffin and were then processed to obtain 5-micron thick paraffin sections. Sections were stained with hematoxylin and eosin and were also subjected to staining with the Naphthol AS-D Chloroacetate Esterase Kit (Sigma, St.
Louis, MO). This technique, which was performed according to the manufacturer's instructions with modifications, allows the determination of chloroacetate esterase activity, which reflects neutrophil infiltration. Briefly, CAF-solution (2.5 mL citrate+ 6.5 mL acetone + 0.8 mL 37% formalin) was added to deparaffinised in xylene and rehydrated in a graded alcohol series sections, for exactly 30 seconds, followed by rinse with water. Subsequently, 
Statistical analysis
Statistical analysis was performed using SPSS statistical software package (vs. 11.5, SPSS, Inc., Chicago, IL). Normality of distribution was determined using Kolmogorov-Smirnov and interquartile range (IQR), as appropriate, and n is the number of rats in each group. 
Results
Effect of intravenous (iv) HES fluid on hepatic function
Effect of iv HES fluid on hepatocellular injury
Effect of iv HES fluid in neutrophil infiltration
The normal (Sh-only, Sh+HES and Sh+HS) rat liver did not exhibit any distinctive evidence of inflammatory cell infiltrate. 
Mortality
There were no deaths. As expected, all the animals awaked uneventfully and reached the defined end-point (24 hours of reperfusion).
Discussion
With the use of in vivo rat liver IRI model, this study demonstrates, for the first time, the ability of HES 130/0.4 to attenuate the hepatic damage in the late-phase of liver IRI.
Treatment of rats subjected to 60 minutes of ischemia followed by 24 hours of reperfusion with intravenous solution of HES significantly reduced hepatic enzyme elevation and necrosis, with a concomitant reduction in neutrophil sequestration into the ischemic liver, when compared with untreated IRI rats.
The biochemical and histological markers used were the most reflective of hepatic injury in the late phase, having been used in many liver studies [9] [10] , and so were chosen to demonstrate the potential protective effect of HES 130/0.4 in this setting; further mechanistic information was obtained by neutrophil staining with
Chloroacetate Esterase to reveal a potential anti-inflammatory action, thereby attending to all objectives defined for this study.
Late-phase ischemia/reperfusion injury (IRI) mechanisms are very different from the early-phase ones, as has been widely Protective perioperative strategy using a third generation hydroxyethyl starch during surgery in a murine model of liver reperfusion injury ischemia, as referred by Kaplan et al. 6 , showed loss of late effect (24h) on neutrophil adherence even though its presence was found in early phases (30 minutes and 2 hours) of injury 11 .
In this study we focused on the action of HES on neutrophil infiltration, as a measure to assess the mechanism by which the HES fluid attenuates the hepatic late IRI in this model.
It is generally accepted that neutrophils play a critical role in pathogenesis of ischemia/reperfusion injury 2 . In this regard it is pertinent to note that neutrophil activation has been long considered the major effector mechanism in liver IRI and promotes tissue injury 
Conclusion
Hydroxyethyl starch suppresses inflammatory response and ameliorates the late-phase response of hepatic ischemia/ reperfusion injury.
